News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement
|Articles|September 29, 2008

ACT June 2008 BPA

ACT June 2008 BPA

Advertisement
External Link - article-555130.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Advertisement

Related Content

Advertisement

ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance

ByAndy Studna, Senior Editor
January 13th 2026

How Community Sites Can Stay Competitive Under Growing Efficiency Pressures

ByLiz Beatty,Andy Studna, Senior Editor
January 13th 2026
© photon_photo - © photon_photo - stock.adobe.com

The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior License Execution Would Significantly Benefit Clinical Trial Set-Up

ByFlorence Mowlem, PhD
January 12th 2026

Moving Beyond Historical Site Data to Real-Time Patient Insight

ByLiz Beatty,Andy Studna, Senior Editor
January 12th 2026

ACT Brief: Trial Competition Slows AI Gains, Rethinking Patient-Level Safety Decisions, and What Separates Real AI Platforms in Clinical Trials

ByAndy Studna, Senior Editor
January 12th 2026
Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Moving Beyond Historical Site Data to Real-Time Patient Insight

2

The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior License Execution Would Significantly Benefit Clinical Trial Set-Up

3

ACT Brief: Trial Competition Slows AI Gains, Rethinking Patient-Level Safety Decisions, and What Separates Real AI Platforms in Clinical Trials

4

Why Trial Competition Is Undermining AI-Driven Gains

5

Verana Health Merges With COTA to Expand Real-World Data Capabilities Across Oncology and Specialty Care

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us